Get the Stockscreener App
7.46
1.91%
0.14
After Hours:
7.46
Scienture Holdings Inc stock is traded at $7.46, with a volume of 10,872.
It is up +1.91% in the last 24 hours and up +0.00% over the past month.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.
See More
Previous Close:
$7.32
Open:
$6.8992
24h Volume:
10,872
Relative Volume:
18.05
Market Cap:
$13.06M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.00%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$6.8992
$7.46
1-Week Range:
$6.8992
$7.6411
52-Week Range:
$6.8992
$7.6411
Scienture Holdings Inc Stock (SCNX) Company Profile
Name
Scienture Holdings Inc
Sector
Industry
Phone
(800) 261 0281
Address
2420 BRUNELLO TRACE, LUTZ
Scienture Holdings Inc Stock (SCNX) Latest News
Scienture Holdings Unveils New Identity Post-Merger - TipRanks
TRxADE Health rebrands as Scienture Holdings with new ticker SCNX - Investing.com
SCNXScienture Holdings, Inc. Latest Stock News & Market Updates - StockTitan
Trxade Health announces name change to Scienture Holdings - TipRanks
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. - StockTitan
TRxADE HEALTH completes all-stock merger deal with Scienture - World Pharmaceutical Frontiers
$103M all-stock transaction merges TRxADE and Scienture, forming new company - Investing.com
TRxADE Health, Inc. Files its Q1 10-Q; Reporting Positive Net Income Due to Asset Sale - StockTitan
Alumis looks to raise $300 million in IPO. Here’s what you need to know - AlphaStreet
Tempus AI gears up for IPO. Here’s everything you need to know - AlphaStreet
Femasys is committed to providing women with revolutionary healthcare products: CEO - AlphaStreet
Nordic Group makes another acquisition to diversify earnings base - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
Continued focus on core B2B segment drives new business: Trxade CEO Suren Ajjarapu - AlphaStreet
Trxade (MEDS) is increasing the breadth of product offerings: CEO Suren Ajjarapu - AlphaStreet
No concerns on margin side: Trxade (MEDS) CEO Suren Ajjarapu - AlphaStreet
MEDS Stock Price and Chart — NASDAQ:MEDS - TradingView
Trxade Group, Inc. Elects Donald Almeida to Board of Directors - Marketscreener.com
Scienture Holdings Inc Stock (SCNX) Financials Data
There is no financial data for Scienture Holdings Inc (SCNX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
5.36%
1.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):